COVID-19 Research Paper Volume 13, Issue 7 pp 9225—9242

Risk factors for systemic and venous thromboembolism, mortality and bleeding risks in 1125 patients with COVID-19: relationship with anticoagulation status

Hazard ratios of clinical events, adjusting for baseline risk factors. (C) Thromboembolism and bleeding events (n=25); (D) Death (n=91); (E) Composite outcomes of thromboembolism, bleeding events, and death (n=235). *HR: hazard ratio. CI: confidential interval.

Figure 1C-E. Hazard ratios of clinical events, adjusting for baseline risk factors. (C) Thromboembolism and bleeding events (n=25); (D) Death (n=91); (E) Composite outcomes of thromboembolism, bleeding events, and death (n=235). *HR: hazard ratio. CI: confidential interval.